Searchable abstracts of presentations at key conferences in endocrinology

ea0016s26.1 | New therapeutic options in diabetes | ECE2008

Islet transplantation

Fiorina Paolo

The morbidity and mortality associated with long-term diabetic complications continue to rise and will remain a major worldwide health problem in the coming years. Islet cell transplantation has recently emerged as one the most promising therapeutic approaches to improving glycometabolic control in diabetic patients and, in many cases, to obtaining insulin independence. Unfortunately, many flaws still persist that make it impossible for islet transplantation to become the gold...

ea0090p76 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Very-low-calorie-ketogenic-diet (VLCKD) as a nutritional therapeutical option for chronic management in obese patients with type 2 diabetes: a case report

Parazzoli Chiara , Volpi Graziella , Morpurgo Paola S. , Gandolfi Alessandra , Mario Bolla Andrea , Fiorina Paolo

Introduction: It is known that very-low-calorie-ketogenic-diet (VLCKD) has beneficial effects on body weight in overweight diabetic patients. Adopting this diet with artificial meals or natural foods in type 2 diabetes (T2DM) has been largely studied, and conflicting results have been reported regarding its effects on glycemic profiles, dyslipidemia, and liver function. In fact, the high level of fat content in natural foods could have a negative impact on hepatic steatosis, a...

ea0081p330 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Time of gestational diabetes diagnosis and neonatal outcomes

Morpurgo Paola S. , Peverelli Laura F. , Bolla Andrea M. , Gandolfi Alessandra , Vignali Michele , Spadaccini Giovanna , Fiorina Paolo

Background: The incidence of gestational diabetes mellitus (GDM) is increasing worldwide, with considerable impact on the health of both mother and newborn. There is no doubt that screening for GDM between 24 and 28 gestational weeks (GWks) is important to reduce the risk of adverse outcomes; however, there is no clear consensus about the diagnosis and treatment of GDM in early pregnancy.Aims: To evaluate the effect of time of GDM diagnosis (early onset ...

ea0090p67 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Study of the prevalence, clinical correlates, and cardiovascular outcomes of central and primary hypogonadism in type 2 diabetes mellitus

Cangiano Biagio , Elena Lunati Maria , Bollino Ruggiero , Conti Antonio , Galazzi Elena , Fiorina Paolo , Persani Luca , Bonomi Marco

Background: In patients affected with type 2 diabetes mellitus (T2DM) a high prevalence of hypogonadism has been reported, even if there is no consensus on its metabolic and cardiovascular implications, especially according to the type of hypogonadism. The aim of this observational study is to evaluate: (1) the prevalence of different types of hypogonadism in T2DM according to validated criteria from the EMAS study; (2) look for correlations of gonadal status with severity or ...